Saturday, June 7, 2025

Monthly Archives: June, 2020

FDA Approves First Therapy for Rare Disease

June 18, 2020: "The U.S. Food and Drug Administration approved Crysvita (burosumab-twza) injection to treat patients age two and older with tumor-induced osteomalacia (TIO),...

Coronavirus (COVID-19) Update: Daily Roundup June 18, 2020

June 18, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA...

Pfizer and Sangamo announced results of its gene therapy for severe hemophilia A

June 18, 2020: "Pfizer Inc. and Sangamo Therapeutics, Inc. announced updated follow-up data from the Phase 1/2 study of giroctocogene fitelparvovec (SB-525,...

RINVOQ™Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis

June 18, 2020: "AbbVie announced upadacitinib (15 mg and 30 mg, once daily) monotherapy met the co-primary endpoints of at least a 75 percent...

Novel Antibody-Drug Conjugate ABBV-3373 Shows Improvement for Rheumatoid Arthritis

 June 10, 2020: "AbbVie, a research-based global biopharmaceutical company announced new data from a Phase 2a study of ABBV-3373, an investigational anti-tumor necrosis factor...

AbbVie and Genmab Announce Broad Oncology Collaboration

 June 10, 2020: "AbbVie and Genmab A/S announced that AbbVie and Genmab have signed a broad collaboration agreement to jointly develop and commercialize...

Kawasaki-like syndrome linked to COVID-19 in children is a new condition

June 08, 2020: "A study on children suffering from severe inflammatory symptoms shows the condition is new and distinct from Kawasaki disease. A study led...

Soleno Therapeutic’s drug misses a key goal in Prader-Willi trial

June 08, 2020: "Soleno Therapeutics announced top-line results from the Company’s Phase III trial, DESTINY PWS (C601), evaluating once-daily Diazoxide Choline Controlled-Release (DCCR) tablets...

Coronavirus (COVID-19) Update: Daily Roundup June 9, 2020

June 09, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On June...

Oxford Biomedica and VMIC Announces Collaboration

June 08, 2020: "Oxford Biomedica plc, a leading gene and cell therapy group, announced that it has signed a Collaboration Agreement with the Vaccines Manufacturing...

Coronavirus (COVID-19) Update: Daily Roundup June 8, 2020

June 08, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On June...

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease

June 8, 2020: "Sanofi will host a virtual scientific session to present data from the Phase 3 COMET trial of investigational enzyme replacement therapy...
- Advertisment -

Most Read